Rob Perez, former President and CEO of Cubist Pharmaceuticals, Inc., has joined General Atlantic, a NYC-based global growth equity firm, as an Operating Partner.
Based in the New York office, Mr. Perez will have a particular focus on the biopharma and life sciences sectors, using his expertise to identify new investment opportunities and support the growth of the firm’s existing investments.
He will be a part of the General Atlantic’s Resources Group, providing strategic counsel to the investment teams and portfolio companies.
Mr. Perez was previously the Managing Director of Vineyard Sound Advisors, LLC, an advisory practice focused on growth companies in the biopharma industry. Before serving in this role, he was President and CEO of Cubist Pharmaceuticals, Inc. prior to its sale to Merck in 2015. Perez joined Cubist in 2003 as Senior Vice President of Sales and Marketing and led the launch of Cubicin® (daptomycin for injection).
Prior to joining Cubist, he served as Vice President of Biogen, Inc.’s CNS Business Unit.
Mr. Perez serves on the board of directors of public companies AMAG Pharmaceuticals (NASDAQ: AMAG), Spark Therapeutics (NASDAQ: ONCE), Unum Therapeutics, Inc. (NASDAQ: UMRX), and Zafgen, Inc. (NASDAQ: ZFGN), as well as private companies Akili Interactive, ImmusanT, and Vir Biotechnology. He is also a member of the board of trustees of the Dana-Farber Cancer Institute, Inc. and the Founder and Chairman of Life Science Cares, Inc.
Mr. Perez earned a B.S. in Business from California State University, Los Angeles and an M.B.A. from the Anderson Graduate School of Management at the University of California, Los Angeles.
Led by Bill Ford, Chief Executive Officer, and Dr. Michelle Dipp, Managing Director, General Atlantic is a global growth equity firm providing capital and strategic support for growth companies.
Established in 1980, the firm focuses on investments across four sectors, including Consumer, Financial Services, Healthcare, and Technology, partnering with entrepreneurs and management teams who are building high-growth businesses.
The firm has approximately $28 billion assets under management as of June 30, 2018. It has more than 150 investment professionals based in New York, Amsterdam, Beijing, Greenwich, Hong Kong, London, Mexico City, Mumbai, Munich, Palo Alto, São Paulo, Shanghai, and Singapore.